Open AccessInterpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
Author(s) -
Kanchan Ajbani,
Swapik,
Mubin Kazi,
Anjali Shetty,
Camilla Rodrigues
Publication year - 2019
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_463_18
Subject(s) - genexpert mtb/rif , medicine , mycobacterium tuberculosis , tuberculosis , rifampicin , microbiology and biotechnology , virology , pathology , biology
The development and rollout of the Xpert ® Mycobacterium tuberculosis/rifampicin assay for the GeneXpert platform is considered an important breakthrough in the fight against tuberculosis. Xpert though robust is known to have issues that occur with very low load of tuberculosis detection, wherein it is recommended to confirm resistance if resistance is not suspected using another genotypic test.